Home › News

News & insights

Notes on supply, manufacturing and regulation.

Occasional writing on the practical side of pharmaceutical availability — the parts that determine whether a medicine reaches a patient, which rarely make the headline.

Placeholder posts. Replace these with real updates. Each entry is a date, a headline and a short summary in the page source — no CMS, no login. Two or three substantial pieces a year will serve you better than a thin monthly cadence.

Pranda Health publishes its corporate website

A first public description of the group’s integrated model across active ingredients, finished dosage manufacturing, global supply chain and clinical services — and of the staged approach that puts measured availability ahead of construction.

Why availability is a data problem before it is a manufacturing problem

Replace with a short piece on demand visibility, safety stock and the difference between a medicine existing in a supply chain and a medicine being on the shelf when a patient presents.

What a credential appendix should contain

Replace with a piece on verification: licence numbers, site scopes, validity dates and inspection history — and the distinctions between certification, prequalification and approval that are routinely blurred.

To add a post, copy one <article class="post"> block in news.html, change the date, headline and summary, then redeploy.

Next step

Prefer a direct conversation?

Most of what matters here is specific to a market and a portfolio. We are happy to discuss yours.